Muscle News and Research

RSS

Study shows taking vitamin D2 supplements may result in higher muscle damage in athletes

Power athletes and others looking for an edge to improve their performance should avoid taking vitamin D2.

28 Jan 2014

Study demonstrates direct effects of fragmented sleep on tumor growth

Poor-quality sleep marked by frequent awakenings can speed cancer growth, increase tumor aggressiveness and dampen the immune system's ability to control or eradicate early cancers, according to a new study published online January 21, 2014, in the journal Cancer Research.

27 Jan 2014

New method allows for large-scale generation of human embryonic stem cells

A new method allows for large-scale generation of human embryonic stem cells of high clinical quality. It also allows for production of such cells without destroying any human embryos.

27 Jan 2014

Scientists provide new insights into molecular regulation of stem cell differentiation

The findings of the scientists of the Institute of Diabetes and Regeneration Research (IDR) at Helmholtz Zentrum München (HMGU) provide new insights into the molecular regulation of stem cell differentiation.

25 Jan 2014

Researchers discover mechanism that controls activity of LRRK2 in Parkinson's disease

In one variant of Parkinson's disease, the enzyme LRRK2 plays a central role. Scientists at the University of Kassel have now discovered a mechanism that controls the activity of LRRK2.

24 Jan 2014

Prostate cancer patients treated with ADT experience mental, emotional well-being during treatment

A new study published in the Journal of Urology- reports that prostate cancer patients treated with androgen deprivation therapy (ADT) experienced changes in mental and emotional well-being during treatment, although there was no meaningful decline in emotional quality of life two years after treatment.

24 Jan 2014

Continuing spinal cord stimulation improves symptoms of Parkinson's disease

Researchers at Duke Medicine have shown that continuing spinal cord stimulation appears to produce improvements in symptoms of Parkinson's disease, and may protect critical neurons from injury or deterioration.

24 Jan 2014

CUMC researchers identify gene that appears to play major role in motor neuron degeneration in ALS

Columbia University Medical Center researchers have identified a gene, called matrix metalloproteinase-9 (MMP-9), that appears to play a major role in motor neuron degeneration in amyotrophic lateral sclerosis, also known as Lou Gehrig's disease. The findings, made in mice, explain why most but not all motor neurons are affected by the disease and identify a potential therapeutic target for this still-incurable neurodegenerative disease. The study was published today in the online edition of the journal Neuron.

23 Jan 2014

CytRx initiates aldoxorubicin Phase 2 trial in HIV-infected patients with Kaposi's sarcoma

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced it has initiated a Phase 2 clinical trial to determine preliminary efficacy and safety of aldoxorubicin for HIV-infected patients with Kaposi's sarcoma.

23 Jan 2014

New heart tissue could help patients suffering from irreparable damage

In the U.S., someone suffers a heart attack every 34 seconds - their heart is starved of oxygen and suffers irreparable damage. Engineering new heart tissue in the laboratory that could eventually be implanted into patients could help, and scientists are reporting a promising approach tested with rat cells.

23 Jan 2014

Joint research program in SMA enters initial stage of clinical development

PTC Therapeutics, Inc., the SMA Foundation, and Roche, announced today that their joint research program in Spinal Muscular Atrophy has entered the first stage of clinical development aiming to assess safety and tolerability of an oral compound in healthy volunteers.

22 Jan 2014

CytRx receives FDA approval to continue dosing aldoxorubicin for patients with soft tissue sarcomas

CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, today announced it has received approval from the U.S. Food and Drug Administration (FDA) to continue dosing patients with aldoxorubicin until disease progression in a planned pivotal, global Phase 3 clinical trial with aldoxorubicin as a second-line treatment for soft tissue sarcomas.

22 Jan 2014

New orthotic device could aid in rehabilitation of patients with ankle-foot disorders

A soft, wearable device that mimics the muscles, tendons and ligaments of the lower leg could aid in the rehabilitation of patients with ankle-foot disorders such as drop foot, said Yong-Lae Park, an assistant professor of robotics at Carnegie Mellon University.

22 Jan 2014

Patients with MS could stave off disease symptoms by increasing vitamin D intake

For patients in the early stages of multiple sclerosis (MS), low levels of vitamin D were found to strongly predict disease severity and hasten its progression, according to a new study led by Harvard School of Public Health (HSPH) investigators in collaboration with Bayer HealthCare.

20 Jan 2014

Study links discrete area of brain to cognitive deficit in people at early stage of PD

Research by a team of investigators in Finland suggests that the free recall memory deficits common even in early stages Parkinson's disease (PD) are related to structural changes in the brain, specifically parietal cortical gray matter volume.

17 Jan 2014

Longer reads: Connecting with patients; obesity origins; children with chronic disease

I'd never [before] been encouraged to sit at a patient's bedside - to stop hurrying for even a moment. Our medical teachers put a premium on accuracy and efficiency, which became conflated with speed.

17 Jan 2014

Higher vitamin D levels linked with better cognition and less depression in PD patients

A new study exploring vitamin D levels in patients with Parkinson's disease (PD) opens up the possibility of a new avenue of early intervention that may delay or prevent the onset of cognitive impairment and depression. The findings are published in the Journal of Parkinson's Disease.

16 Jan 2014

Study links a discrete area of the brain to cognitive deficit in people at early stage of PD

Research by a team of investigators in Finland suggests that the free recall memory deficits common even in early stages Parkinson's disease are related to structural changes in the brain, specifically parietal cortical gray matter volume. Their findings are published in the current issue of the Journal of Parkinson's Disease.

16 Jan 2014

Researchers find new way to boost survival of pediatric patients suffering cardiac arrest

Researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford have found a new way to boost the survival of pediatric patients whose hearts stop while they are hospitalized.

16 Jan 2014

New discovery has potential to transform heart attack treatments

An Australian discovery has the potential to transform the treatment of a heart attack, after a new approach boosted heart function and reduced heart scarring in preclinical studies.

16 Jan 2014

Muscle News and Research

Study shows taking vitamin D2 supplements may result in higher muscle damage in athletes

Study demonstrates direct effects of fragmented sleep on tumor growth

New method allows for large-scale generation of human embryonic stem cells

Scientists provide new insights into molecular regulation of stem cell differentiation

Researchers discover mechanism that controls activity of LRRK2 in Parkinson's disease

Prostate cancer patients treated with ADT experience mental, emotional well-being during treatment

Continuing spinal cord stimulation improves symptoms of Parkinson's disease

CUMC researchers identify gene that appears to play major role in motor neuron degeneration in ALS

CytRx initiates aldoxorubicin Phase 2 trial in HIV-infected patients with Kaposi's sarcoma

New heart tissue could help patients suffering from irreparable damage

Joint research program in SMA enters initial stage of clinical development

CytRx receives FDA approval to continue dosing aldoxorubicin for patients with soft tissue sarcomas

New orthotic device could aid in rehabilitation of patients with ankle-foot disorders

Patients with MS could stave off disease symptoms by increasing vitamin D intake

Study links discrete area of brain to cognitive deficit in people at early stage of PD

Longer reads: Connecting with patients; obesity origins; children with chronic disease

Higher vitamin D levels linked with better cognition and less depression in PD patients

Study links a discrete area of the brain to cognitive deficit in people at early stage of PD

Researchers find new way to boost survival of pediatric patients suffering cardiac arrest

New discovery has potential to transform heart attack treatments

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News